Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11363
Title: Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
Authors: Norman, Trevor R;Cranston, Ingrid;Irons, Jeremy A;Gabriel, Cecilia;Dekeyne, Anne;Millan, Mark J;Mocaër, Elisabeth
Affiliation: Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia. trevorrn@unimelb.edu.au
Issue Date: 21-Oct-2011
Citation: European Journal of Pharmacology 2011; 674(1): 27-32
Abstract: The novel melatonergic agonist/5-HT(2C) antagonist agomelatine displays robust antidepressant properties in humans and is active in pre-clinical models predictive of antidepressant effects. In this study, we investigated its potential influence on the locomotor hyperactivity displayed by olfactory bulbectomised rats, a putative measure of potential antidepressant activity. In addition, we compared the actions of agomelatine to those of melatonin and S32006, a selective antagonist at 5-HT(2C) receptors. Vehicle, agomelatine (10 and 50mg/kg), melatonin (10 and 50mg/kg), S32006 (0.16mg/kg to 10mg/kg) and the prototypical tricyclic antidepressant, imipramine (10mg/kg), were administered by intraperitoneal injection for 14days to male, Sprague-Dawley sham-operated and bulbectomised rats. In agreement with previous studies, imipramine was active in the model and both the lower and higher doses of agomelatine also significantly and markedly reversed the bulbectomy-induced hyperactivity to a level comparable to that seen in sham operated animals, in which agomelatine exerted no effect. Similarly the 5-HT(2C) antagonist, S32006, dose-dependently and significantly attenuated hyperactivity of bulbectomised animals, albeit with a maximal effect somewhat less marked than that of agomelatine. On the other hand, melatonin did not affect the locomotor behaviour of bulbectomised rats. The activity of agomelatine in the model is consistent with its known antidepressant properties in the clinic.
Internal ID Number: 22040921
URI: http://ahro.austin.org.au/austinjspui/handle/1/11363
DOI: 10.1016/j.ejphar.2011.10.010
URL: http://www.ncbi.nlm.nih.gov/pubmed/22040921
Type: Journal Article
Subjects: Acetamides.pharmacology.therapeutic use
Animals
Antidepressive Agents.pharmacology.therapeutic use
Behavior, Animal.drug effects
Hyperkinesis.drug therapy
Indoles.pharmacology.therapeutic use
Male
Melatonin.pharmacology.therapeutic use
Olfactory Bulb.surgery
Pyridines.pharmacology.therapeutic use
Rats
Rats, Sprague-Dawley
Receptor, Serotonin, 5-HT2C.metabolism
Serotonin 5-HT2 Receptor Antagonists.pharmacology.therapeutic use
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.